Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.
about
The immunogenicity of colorectal cancers with high-degree microsatellite instabilityHeat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of CancerLysosomal rerouting of Hsp70 trafficking as a potential immune activating tool for targeting melanoma.Chaperokine function of recombinant Hsp72 produced in insect cells using a baculovirus expression system is retained.Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human esophageal squamous cell carcinomaAnti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneanaHsp74, a potential bladder cancer marker, has direct interaction with keratin 1.Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implicationsInduction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases.Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.Bap, a biofilm matrix protein of Staphylococcus aureus prevents cellular internalization through binding to GP96 host receptorExpression and significance of heat shock protein 70 and glucose-regulated protein 94 in human esophageal carcinomaN-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine.Correlation between clinicopathology and expression of heat shock protein 70 and glucose-regulated protein 94 in human colonic adenocarcinoma.Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice.Chaperone proteins and brain tumors: potential targets and possible therapeutics.Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunityEscape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.Heat shock proteins and scavenger receptors: role in adaptive immune responses.Emerging drugs for renal cell carcinoma.Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccinationDecoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.Heat-shock protein vaccines as active immunotherapy against human gliomas.Recent advances in DNA vaccines for autoimmune diseases.Heat shock proteins in cancer: targeting the 'chaperones'.Tumor immunotherapy based on tumor-derived heat shock proteins (Review).HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis.Targeting Hsp70: A possible therapy for cancer.CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease.Unconventional Secretion of Heat Shock Proteins in Cancer.Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.Co-expression of heat shock protein 70 and glucose-regulated protein 94 in human gastric carcinoma cell line BGC-823Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion.Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70.Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators.Hsp70: A Cancer Target Inside and Outside the Cell.Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck
P2860
Q24814928-B919D377-73DB-485E-9D12-B2467664C9CAQ26747392-7A2BFD0D-3EAF-4236-8FE1-765A9EF9FDAFQ30530764-B6E2FD5D-3A07-4C47-927B-FD3AF96B120DQ33581297-0172E56D-8983-4BB0-8543-4A4DDB305676Q33719233-EC19F82B-C21B-4877-A2BA-591620387B0DQ33788573-2EBAB0FC-937B-4CA4-AC09-1115CC5CE184Q33891329-ECE5C9A7-1D16-45B7-969A-3B640DE31657Q33899708-C629067E-C35E-4807-B598-F73795C71689Q33914458-13354437-CC81-4BA0-AD7F-2B851005F9E4Q34179630-FF1E798A-A2CF-47DA-AFBB-B38DC56825B7Q34372327-53D2A2F9-FFB7-4DA1-A9E0-6D987FBEA10FQ34382373-24727F69-C80E-4D6E-90E0-E60194FCE4D5Q34427467-70F3DA0B-ABF8-4E26-BEE5-DDA26C97275EQ34605577-6D662813-8A2C-41AE-B714-BFD93D79823AQ35010256-F30BEA2B-322D-493F-B491-883E2FA3A8CAQ35800492-62F98E13-B9F5-499F-83FF-FA482A5D0BCEQ35902972-7459643B-EAB2-4233-BD5F-31D4FB831224Q36000449-478DC2E2-A924-4EB1-8030-70BB83C99071Q36150417-72126741-0283-40BB-BE46-37778CE431DFQ36239656-383A6298-0421-4ADB-912F-891137892577Q36246603-5797915E-38D5-4733-9CA0-3E4D5D4CE9D9Q36302842-8AFD1A0B-289B-4890-A165-A46391D64F0DQ36489891-0773F983-8A1D-46EE-B983-7DC5A7F3EDE2Q37002810-AC53548A-4426-42C1-8306-3063475340CCQ37331708-166AF193-19FD-4B2E-9AED-E94E364D1B5FQ37386307-2E12CC23-239A-41F1-B46A-8E3045BE3515Q38008726-C5EBDB03-2C0F-46C6-AD5B-0BD81D1D83E6Q38164708-7D386897-B300-4DA3-8259-D0148CC246E2Q38308716-6016474C-016B-4299-A127-D38EF8DCFBBCQ38742944-C9A88BF1-F82C-4781-8AAC-F6FB6DAAD4A9Q39065654-C8EDBA53-A30B-473A-9E0C-90DE73D9B7D1Q39281019-C16C0870-0ADE-4E90-855D-1D814FAF883EQ39963921-97BF0A69-0A03-434D-B794-44DF070FCC04Q40135301-A1269DF9-B34E-456B-BBBF-879794222D72Q40408239-6B92DEC0-3BA3-4DF4-89A8-BD035C756898Q43245507-9CFEF882-118F-4976-9BBC-F4C52F125090Q45235059-A5ED1A95-B313-4FC7-BFAD-A9CDDC5E637DQ46769764-D83EA1E8-BCAE-45BB-AC4A-8AF30A6F47EAQ47362469-37DC6FCA-A360-4BC8-8714-735F7E571A07Q56786021-94DBF003-25F8-4CDB-8AC0-9CFFD039E65D
P2860
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Heat shock proteins: biologica ...... zed vaccines for human cancer.
@ast
Heat shock proteins: biologica ...... zed vaccines for human cancer.
@en
type
label
Heat shock proteins: biologica ...... zed vaccines for human cancer.
@ast
Heat shock proteins: biologica ...... zed vaccines for human cancer.
@en
prefLabel
Heat shock proteins: biologica ...... zed vaccines for human cancer.
@ast
Heat shock proteins: biologica ...... zed vaccines for human cancer.
@en
P2093
P50
P1476
Heat shock proteins: biologica ...... ized vaccines for human cancer
@en
P2093
Alessandro Testori
Filiberto Belli
Francesca Rini
Giorgio Parmiani
Pramod K Srivastava
P2888
P304
P356
10.1007/S00262-003-0481-9
P577
2003-12-19T00:00:00Z